Type 1 interferons (IFNs; IFNa/b) mediate immunological host resistance to numerous viral infections, including herpes simplex virus type 1 (HSV-1). The pathways responsible for IFNa/b signaling during the innate immune response to acute HSV-1 infection in the cornea are incompletely understood. Using a murine ocular infection model, we hypothesized that the stimulator of IFN genes (STING) mediates resistance to HSV-1 infection at the ocular surface and preserves the structural integrity of this mucosal site. Viral pathogenesis, tissue pathology, and host immune responses during ocular HSV-1 infection were characterized by plaque assay, esthesiometry, pachymetry, immunohistochemistry, flow cytometry, and small interfering RNA transfection in wild-type C57BL/6 (WT), STING-deficient (STING À / À ), and IFNa/b receptor-deficient (CD118 À / À ) mice at days 3-5 postinfection. The presence of STING was critical for sustained control of HSV-1 replication in the corneal epithelium and resistance to viral neuroinvasion, but loss of STING had a negligible impact with respect to gross tissue pathology. Auxiliary STING-independent IFNa/b signaling pathways were responsible for maintenance of corneal integrity. Lymphatic vessels, mast cells, and sensory innervation were compromised in CD118 À / À mice concurrent with increased tissue edema. STING-dependent signaling led to the upregulation of tetherin, a viral restriction factor we identify is important in containing the spread of HSV-1 in vivo.
INTRODUCTION
Viral infections set off cellular alarms through the detection of pathogen-associated molecular patterns. Virus-derived pathogen-associated molecular patterns are recognized by a variety of innate sensors that operate through distinct signaling pathways to upregulate interferon a/b (IFNa/b) and stimulate nuclear factor-kB-driven cytokine production. 1 IFNa/b secretion mediates canonical autocrine and paracrine signaling through the IFNa/b receptor (CD118). The IFNa/b signaling pathway modulates hundreds of IFN-stimulated genes (ISGs), the products of which activate immunological countermeasures and promote host resistance to viral infections. 2 Specific host-pathogen interactions ultimately dictate the effectiveness of IFNa/b signaling, as many viruses, including HSV-1, employ numerous mechanisms to evade, counteract, or otherwise disrupt pathway components or downstream ISGs. 3, 4 Multiple pattern-recognition receptor families can initiate IFNa/b signaling during DNA virus infections. [5] [6] [7] The pathways by which HSV-1-derived pathogen-associated molecular patterns mediate IFNa/b induction and host resistance within mucosal sites are incompletely understood. Our laboratory has previously shown that loss of toll-like receptor (TLR) signaling does not enhance HSV-1 pathogenesis in the cornea; rather, a TLR-independent pathway involving the STING-dependent DNA sensor IFI16 (IFN inducible protein 16) initiates host resistance to HSV-1 in the corneal epithelium. 8 STING operates as a direct sensor of cytosolic DNA and a central signaling adaptor protein for an array of cytoplasmic and nuclear DNA sensors. 6, 9 STING-dependent induction of IFNa/b involves activation of the transcription factor IFN regulatory factor 3 (IRF3) via phosphorylation by TANK-binding kinase 1 (TBK1). 10 IFI16 has been linked to early IFNb production in HSV-1-infected monocyte/macrophage cell lines, fibroblasts, and in the corneal epithelium. 8, 11, 12 However, IFI16 is degraded by the HSV-1 early gene product ICP0, suggesting that the STING-TBK1-IRF3 signaling axis is essential for early detection of viral infection but may be subsequently counteracted by the virus. 11, 13, 14 We investigated the role of STING in sustained IFNa/b signaling in a mouse model of ocular HSV-1 infection and hypothesized that STING mediates innate host resistance to corneal HSV-1 infection and preserves the corneal integrity through day 5 postinfection (pi).
Currently, there are no prophylactic or therapeutic vaccines licensed to prevent sequelae elicited by HSV-1 infection. 15 These medically relevant pathologies span in severity from intermittent mucocutaneous lesions (i.e., oral and genital herpes, herpetic keratitis) to neurological damage and corneal blindness. 16 The cornea is a delicate mucosal site, and pathological alteration of the tissue architecture hinders visual acuity. Recurrent corneal HSV-1 infection contributes to a variety of pathological sequelae in the human cornea that can affect visual acuity and health of the ocular surface, including edema, scarring, neovascularization, and loss of sensation. 15, 17 Our investigation highlights the subtleties of IFNa/b-signaling pathways in promoting resistance to ocular HSV-1 infection. Resistance to HSV-1 involves the coordinated activities and interactions of many cell types and structures in the cornea to detect the viral infection, limit local replication, and impede spread to peripheral nerve ganglia. Our findings collectively identify that the STING signaling axis is critical for host resistance to corneal HSV-1 infection through a mechanism involving the viral restriction factor tetherin (also known as BST2, CD317, HM1.24, PDCA-1). A wealth of evidence supports tetherin as a viral restriction factor active against a diverse range of enveloped viruses in vitro and in vivo by impeding cell-cell spread of nascent virions. [18] [19] [20] We show that tetherin limits HSV-1 replication in the corneal epithelium and impedes viral dissemination to the nervous system.
RESULTS

STING promotes sustained resistance to HSV-1 replication in the eye
To identify the impact of STING relative to acute HSV-1 infection of the ocular surface, HSV-1 infection of the cornea was modeled using wild-type (WT) C57BL6/J, STINGdeficient (STING À / À ), and highly susceptible IFNa/b receptor-deficient (CD118 À / À ) mice. By day 5 pi, STING À / À and CD118 À / À mice harbored significantly more infectious virus in the cornea than WT mice (Figure 1a) . A moderate increase in titer comparing CD118 À / À mice to STING À / À mice was also observed (Figure 1a) . This data indicates that the STING-signaling pathway is a major determinant of IFNa/bdependent host resistance within the cornea following HSV-1 infection.
STING deficiency does not exacerbate acute corneal pathology
Corneal sensation and edema were measured following HSV-1 infection via Cochet-Bonnet esthesiometry and ultrasound pachymetry, respectively. WT mice had no appreciable changes in corneal sensation (Figure 1b) relative to healthy controls (not shown) by day 5 pi, though significant sensation loss and corneal denervation is observed in WT mice by day 8 pi using this experimental model. 21 In contrast, CD118 À / À mice exhibited hyperacute corneal sensation loss such that the pressure required to elicit a blink response was 15 g mm À 2 higher than WT by day 5 pi (Figure 1b) .
Despite the similar magnitude of infectious virus recovered from the corneas of STING À / À and CD118 À / À mice, corneal sensation loss relative to WT was not observed in STING À / À mice through day 5 pi (Figure 1b) . Corneas of CD118 À / À mice were more edematous than either STING À / À or WT mice by day 3 pi (Figure 1c) . The severity of corneal edema continued to worsen in CD118 À / À mice through day 5 pi, while differences in corneal thickness observed in WT and STING À / À mice following infection were generally unremarkable compared with baseline uninfected (UI) controls (Figure 1c) . Moreover, the mechanism underlying HSV-1-associated corneal sensation loss is likely dependent on intrinsic cell-signaling pathways and is not merely attributable to infection of the sensory neurons, as STING À / À and CD118 À / À mice harbored 100-1,000 times more infectious virus in the trigeminal ganglion (TG) than WT by day 5 pi (data not shown; Pp0.001).
STING promotes host resistance in the corneal epithelium and restrains HSV-1 neuroinvasion
Confocal imaging was employed to visualize the localization of HSV-1 antigen in the cornea whole mounts at day 5 pi. Viral lesions were geographically isolated in the WT corneas, whereas diffuse HSV-1 labeling was observed in the STING À / À and CD118 À / À corneas (Figure 1d ). Highmagnification confocal analysis of the viral lesions revealed that HSV-1 antigen is present almost exclusively in the outermost epithelial layers of WT and STING À / À corneas but penetrates into the deeper stromal layers of CD118 À / À corneas ( Figure 1e) .
The pathogenesis of HSV-1 involves neuroinvasion and retrograde dissemination to the tissue-innervating TG following infection of the oculo-orofacial mucosae. Subbasal sensory nerve fibers of TG neurons innervate the corneal epithelium and enable direct epithelial-nerve spread of HSV-1. CD118
and STING À / À mice harbored 100 times more infectious HSV-1 in the TG than in WT as early as day 3 pi (see Supplementary Figure S1a online), indicating that STING-mediated signaling restricts dissemination of HSV-1 from the corneal epithelium to the nervous system.
STING deficiency leads to a minimal reduction in ISG expression
We hypothesized that the STING signaling axis drives and sustains IFNa/b production in the cornea following HSV-1 infection. To investigate this hypothesis, a modest gene array was utilized to measure downstream ISGs at day 5 pi. Cluster image mapping ( Figure 2a ) and quantification (Figure 2b ) of compiled data show comparatively similar profiles for WT and STING À / À mice and a paucity of transcript expression in CD118 À / À mice with respect to genes upregulated by IFNa/ b-signaling. Still, other genes are repressed by IFNa/b signaling 22 such as Wars, which exhibits higher expression in the CD118 À / À group than in WT or STING À / À samples ( Figure 2b) .
Statistical analysis divulged a reduction in transcript expression comparing STING À / À to WT mice for Bst2, Irf3, Irf9, Oas2, Oas3, and Rnasel ( Figure 2b ). Of these, the viral restriction factor Bst2 (tetherin) was the only transcript identified with pronounced margins of differential expression. Tetherin was highly upregulated in the WT corneas yet expression was nearly 10 times lower in the STING À / À and CD118 À / À corneas (Figure 2b) , consistent with the observed differences in viral pathogenesis in our model (Figure 1a) . Despite being statistically significant, expression differences in the other genes of interest were less impressive and not pursued.
Amplified myeloid cell recruitment is observed in STING-deficient mice
To uncover the immunological mechanisms responsible for STING-dependent resistance to HSV-1 in the cornea, infiltrating leukocytes and cytokine concentrations were investigated. Flow cytometry was used to evaluate and characterize the cornea-infiltrating myeloid cells at day 5 pi. STING À / À mice had nearly twice as many total infiltrating myeloid cells (CD45 þ CD11b þ ) as WT mice (Figure 3a) . Confocal microscopy was used to confirm uniform distribution of CD11b þ cells throughout cornea flat mounts at day 5 pi for all three genotypes (data not shown). WT and CD118 À / À mice had comparable total numbers of infiltrating myeloid cells (Figure 3a) . Ly6C and Ly6G antigens were used to distinguish monocytes and neutrophils. No statistical difference was measured in the total number of cornea-infiltrating Ly6C low Ly6G
hi neutrophils comparing WT, STING À / À , and CD118 À / À mice, although there was a propensity for the proportion of neutrophils to be elevated in CD118
À / À mice ( Figure 3b ).
Differences were observed in Ly6C þ cornea-infiltrating monocytes at day 5 pi. We identified two distinct Ly6C þ (mid-high) monocyte populations comprising Ly6G À / À corneas relative to UI at day 3 pi (not shown). Concentrations of the monocyte-chemotactic C-C motif chemokine ligands CCL2 and CCL20 were elevated in the STING À / À corneas at day 5 pi (Figure 3h ), thus providing a mechanistic explanation for the observed enhancement in monocyte infiltration. 23, 24 Production of the proinflammatory cytokines interleukin (IL)-1b and IL-17 were also measured (Figure 3i ), but the concentrations detected did not correlate with severity of tissue pathology or viral pathogenesis.
In order to rule out a potential functional defect in the inflammatory monocytes in STING À / À mice, CD11b Figure S2a) . By 48 h pi, similar findings were observed in culture supernatants with a subtle variance at one multiplicity of infection in which there was a modest but statistically significant increase in HSV-1 recovered from the infected CD11b þ STING À / À cell cultures (Figure 3j ). Prior to isolation of CD11b þ cells, splenocytes isolated from healthy WT and STING À / À mice had a similar distribution of CD45 þ CD11b þ myeloid cell subsets based Consistent with previous findings, 25 macrophages isolated from STING À / À mice exhibited a deficit in major histocompatibility class II (MHC II) upregulation relative to WT in HSV-1-infected cultures (see Supplementary Figure S2d) . However, MHC II expression profiles were similar in both Corneal neovascularization and/or impairment of the peri-corneal vasculature were examined to further characterize differences in acute ocular pathology following HSV-1 infection. Blood and lymphatic vessels were labeled using anti-CD31 and anti-Lyve-1 antibodies, respectively, to visualize the peri-corneal vasculature at day 5 pi (Figure 4a ). The vasculature of STING À / À mice resembled WT (Figure 4a ). Neovascularization was modest in the WT and STING À / À mice and notably absent in the CD118 À / À animals by day 5 pi (Figure 4a ) relative to healthy UI corneas (not shown). The peri-corneal blood vessels remaining in CD118 À / À mice were distended relative to those seen in STING À / À or WT mice ( Figure 4a ) consistent with observations of enhanced tissue edema in CD118 À / À mice ( Figure 1c) . Moreover, a profound loss of lymphatic vasculature is observed in CD118 À / À mice by day 5 pi (Figure 4a ).
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Tissue-resident mast cells associated with the peri-corneal vasculature were also investigated at day 5 pi owing to their pleiotropic immunomodulatory capacity 27 and protective role against ocular HSV-1 infection. 28 Mast cells were identified by avidin staining and found in the limbal aspect of the corneas of WT and STING À / À mice as previously described. 28 In stark contrast, mast cells were lost in the corneas of CD118 À / À mice by day 5 pi (Figure 4b) . We speculate the pathological corneal edema observed in CD118 À / À mice results from multiple mechanisms, including: penetration of HSV-1 into the stroma, lymphatic vessel destruction, and loss of mast cells.
STING is required for tetherin expression in the corneal epithelium
A direct STING-dependent mechanism responsible for containment of viral replication and dissemination remained to be identified. Because of its expression profile in the ISG array, the viral restriction factor tetherin (also known as BST2, CD317, HM1.24, PDCA-1) was explored as a candidate in controlling HSV-1 in the corneal epithelium. We hypothesized that tetherin impedes spread of HSV-1 in the cornea in a STING-dependent manner. Immunolabeling in the WT, STING À / À , and CD118 À / À corneas at day 5 pi was utilized to identify the presence and localization of tetherin (Figure 4c ).
Tetherin colocalized with the CD31
þ blood vessels in all groups. In contrast, high levels of tetherin protein expression was observed in the corneal epithelium of WT but not in STING À / À or CD118 mice À / À (Figure 4c ). Tetherin expression was not observed in uninfected corneal epithelium (not shown). Supplementary Movie S1 highlights the differential expression of tetherin in the epithelium by three-dimensional confocal reconstructions of WT and STING À / À corneas. Punctate tetherin labeling in the deeper stromal layers of the corneas show infiltrating leukocytes, which also express tetherin (see Supplementary Movie S1).
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Tetherin expression was also evaluated in the TG by PCR at day 5 pi (see Supplementary Figure S1b 
and CD118
À / À mice observed herein (see Supplementary  Figure S1a ). Though STING is required for tetherin expression in the corneal epithelium (Figure 4c , see Supplementary Movie S1), tetherin is upregulated in the TG of STING À / À mice similarly to WT at an approximate eightfold increase over UI yet conspicuously absent in CD118 À / À TG at day 5 pi (see Supplementary Figure S1b) . The differential induction of tetherin exemplifies the specificities and complexities of IFNa/ b-mediated ISG stimulation in various tissues. Furthermore, it emphasizes that different antiviral mechanisms control HSV-1 replication in different constituent cell types.
Tetherin impedes local HSV-1 spread and neuroinvasion
Lack of tetherin expression in the corneal epithelium of STING À / À and CD118 À / À mice correlated with the observed increases in HSV-1 titers and unencumbered expression of HSV-1 antigen throughout the epithelium compared with WT animals. However, definitive evidence substantiating the role of tetherin in impeding local viral replication and neuroinvasion remained to be shown. Small interfering RNA (siRNA) transfection was used to limit tetherin expression in the corneas of WT mice pursuant to HSV-1 infection independent of ancillary IFNa/b-signaling deficiencies. Knockdown efficiency (Figure 5a ) was 470% at 48 h pi at the transcript level, and trends in expression differences persisted at 72 h pi. However, transcript expression differences were not statistically significant by the latter time point, therein demonstrating the transient nature of siRNA-mediated knockdown. Knockdown was validated at the protein level using confocal imaging to analyze the fluorescence intensity of tetherin immunolabeling in scramble and tetherin-specific siRNA-treated corneas at 72 h pi (Figure 5b,c) . Isotype control antibody labeling was used to validate the specificity of tetherin immunolabeling (Figure 5b ).
Viral burden in the corneas and TG (Figure 5d ) of siRNAtreated mice was subsequently measured. Local tetherin knockdown in the corneal epithelium led to a significant increase in HSV-1 titer in the cornea and TG compared with scramble siRNA-transfected controls at day 3 pi (Figure 5d ). (d) HSV-1 titers in individual scramble control and tetherin-specific siRNA-transfected mouse corneas (representative data from one of two experiments shown; n ¼ 6-7 corneas/group total) and TG (n ¼ 8-9 TG/group; three independent experiments); * ¼ Po0.05 comparing scramble siRNA to tetherin siRNA-transfected groups.
Consistent with the temporary effect of tetherin knockdown, no differences in viral titer were observed by day 5 pi in the cornea or TG (not shown) comparing the two siRNA-treated groups. Collectively, our data show that tetherin is indeed a functional viral restriction factor for HSV-1 in vivo. Specifically, we show that tetherin expression in the corneal epithelium is STING dependent. Furthermore, we demonstrate that tetherin sequesters HSV-1 in the microenvironment of the corneal epithelium in order to inhibit local cell-cell spread, impede invasion of sensory nerve fibers, and consequentially restrict viral dissemination to the nervous system.
DISCUSSION
Early IFNa/b induction through pathogen-recognition receptor signaling is critical for the control of HSV-1 infection. Our previously reported data show that corneal viral titers in MyD88-or TRIF-deficient mice are no different than WT by day 5 pi; 8 however, the corneal HSV-1 titer at day 5 pi in STING À / À mice was more consistent with the highly susceptible CD118
À / À mice in the present study. Collectively, our data demonstrate that a TLR-independent, STINGdependent process mediates initial and sustained resistance to acute HSV-1 infection in the cornea prior to the induction of an adaptive immune response.
The basic resident cell composition of the murine cornea includes epithelial cells, stromal keratocytes, and endothelial cell layers in addition to tissue-resident leukocytes, sensory nerve fibers, and peripheral vasculature. Each of these cell types and structures likely provide distinct contributions to defense against HSV-1 infection that collectively combat viral replication and spread. Likewise, corneal HSV-1 infection may directly or indirectly elicit unique pathologies affecting each of these components. Blood and lymphatic vessels surrounding the cornea have unique roles during infection by facilitating leukocyte influx and efflux of extracellular fluid and macromolecules, respectively.
Stark differences were observed with respect to corneal pathology comparing STING À / À to CD118 À / À mice despite a similar viral burden. The severe corneal edema exhibited by CD118 À / À mice correlated with a hyperacute sensory deficit following HSV-1 infection. These findings support established notions that inflammatory processes in the cornea induce loss of innervation and that local trophic factors maintain or restore the delicate corneal sensory fibers following injury or pathogenic insult. 21, 32, 33 The present investigation expands the mechanistic understanding of corneal denervation following HSV-1 infection by identifying that sensation loss transpires independent of the viral burden locally in the cornea or in the TG.
Corneal HSV-1 infection with high-titer inoculums can elicit inflammatory neovascularization during the acute stage of infection. 34 Moreover, lymphatic vessels are infected and destroyed by HSV-1 in the absence of IFNa/b signaling. 26 Observations from the present investigation suggest that while STING is critical for containment of HSV-1 replication and spread in the corneal epithelium, an auxiliary STING-independent yet IFNa/b-dependent pathway protects the corneal stroma and peripheral lymphatic vessels from HSV-1 infection and resultant edema.
The selective loss of mast cells in CD118 À / À but not in STING À / À mice again supports the importance of STINGindependent IFNa/b-signaling pathways in the maintenance of the corneal architecture. Mast cells likely provide support for peri-corneal lymphatic vessels and may also contribute to inflammatory lymphangiogenesis in the cornea as has been shown in other sites. [35] [36] [37] Our findings collectively emphasize the importance of IFNa/b-signaling not only with respect to its antiviral properties but also highlight its role in maintaining tissue integrity and preservation of visual acuity.
Multiple studies have established that IFNa/b signaling in both resident and bone marrow-derived cells is critical for resistance to acute HSV-1 infection in the cornea. 23, 26 We observed a profound increase in the myeloid cell infiltrate in the corneas of STING À / À mice relative to WT consistent with a recent report describing the role of STING-dependent suppression of excessive immune activation. 38 Our laboratory has previously shown that, of the infiltrating myeloid-lineage leukocytes, inflammatory monocytes (CD45 þ Gr-1 þ F4/80 þ ) facilitate virus clearance and are recruited by CCL2 following acute HSV-1 infection in the cornea. 23 We have now identified two distinct monocyte populations in the cornea at day 5 pi. Of these, the Ly6C þ Ly6G low population reflects protective inflammatory monocytes. The secondary Ly6C þ Ly6G high monocyte population observed in the cornea has been described in hypoxic metastatic niches [39] [40] [41] and during pulmonary viral infection concomitant with a lack of IFNa/b signaling and altered chemokine production. 42 The concept of distinct monocyte subsets with notable plasticity, phenotypic variation, and functional diversity is now well established for a wide variety of pathologies. [43] [44] [45] [46] [47] Inflammatory monocytes are efficiently recruited to the corneas of STING À / À mice and prevent excessive tissue pathology beyond the surface barrier epithelium. In vitro data indicate that human macrophages and murine myeloid dendritic cells utilize a STING-dependent pathway for recognition of HSV-1 and subsequent induction of IFNb, cytokine production, and autophagy.
48-50 Accordingly, we investigated MHC II upregulation as an indicator of monocyte activation in the absence of STING and found no defect compared with WT monocytes in vitro, though a defect in MHC II upregulation was observed in STING À / À macrophages (see Supplementary Figure S2c,d) .
Antiviral restriction factors serve as wardens for controlling viral infections by arresting virus replication and spread. Tetherin is a type II transmembrane protein that shares topographical homology with several prion proteins which express multiple membrane anchors, including a glycosylphosphatidylinositol anchor. 20 Tetherin is upregulated by IFN signaling (IFNa/b, IFNg, and IFNl) and is inducible in polarized epithelial cells, constitutively expressed by blood vessel endothelial cells and many leukocytes. 18, 29, 51 Tetherin promotes endocytosis and degradation of enveloped virions bound to the cell surface, and is implicated in transcription of nuclear factor-kB-regulated cytokines. 52 Following successful replication of HSV-1 in epithelial cell nuclei, nascent HSV-1 virions must egress through the nuclear membrane, trans-Golgi network, and plasma membrane to infect neighboring cells. 53 The glycosyl-phosphatidylinositol anchor of tetherin facilitates attachment to and retention of enveloped viruses upon virion budding from the trans-Golgi network and plasma membranes to reduce cell-cell spread. 54 Furthermore, reports indicate that HSV-1 employs at least two distinct mechanisms to counteract tetherin and evade restriction in vitro. 55, 56 However, the in vivo relevance of tetherin with respect to HSV-1 infection has not been reported. Our in vivo data show that tetherin sequesters HSV-1 replication and spread in the cornea in addition to neurotropic spread of the virus to peripheral nerve ganglia. Furthermore, our findings detail a novel mechanism of HSV-1 restriction involving a STING-dependent, IFNa/b-mediated signaling pathway that induces tetherin expression on epithelial cells of the ocular mucosae.
METHODS Mice and virus. C57BL/6J WT and STING
À / À mice were obtained from the Jackson Laboratory (Bar Harbor, ME). CD118
À / À and STING À / À mice were bred in-house. All mice were maintained in a specific pathogen-free vivarium at the Dean McGee Eye Institute (University of Oklahoma Health Sciences Center, Oklahoma City, OK). Mice were euthanized by cardiac perfusion with 10-15 ml of 1 Â phosphate-buffered saline (PBS). All experimental procedures were conducted in accordance with protocols approved by Institutional Animal Care and Use Committees. HSV-1 strain McKrae was used for all experiments; the stock concentration was 7.07 Â 10 7 plaque-forming units per ml.
Infection and plaque assays. Six-12-week-old mice were anesthetized by ketamine (100 mg kg À 1 ) and xylazine (6.6 mg kg À 1 ) injection intraperitoneally. Following partial epithelial debridement of the cornea using a 25-gauge needle, an inoculum of 1,000 plaque-forming units of HSV-1 was applied to each eye. Tissues collected from euthanized animals for standard plaque assays were homogenized, and supernatants were titered on confluent CCL-81 Vero cell (ATCC, Manassas, VA) monolayers in microtiter plates as described previously. 28 Corneal pathology. Ultrasound pachymetry was utilized to monitor corneal thickness and edema following infection using a Corneo-Gage Plus digital pachymeter (Sonogage, Cleveland, OH) as described previously. 28 Corneal sensation or blink reflex sensitivity was evaluated using a handheld Cochet-Bonnet esthesiometer (Luneau SAS, Chartres, France) as described previously. 21 Cochet-Bonnet filament length scores were interpolated into threshold sensitivity pressures using conversions provided by the manufacturer.
Gene array. Transcript expression studies on corneas were performed using PrimePCR pathway analysis technology from Bio-Rad (Hercules, CA) for selected genes according to the manufacturer's directions. RNA was isolated from the corneas and converted into cDNA as described previously. 8 Relative gene expression was calculated by the standard 2 À DDCt method using GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and TBP (TATA box-binding protein) as reference genes following semi-quantitative real-time PCR using a CFX Connect thermocycler and PrimePCR technology (Bio-Rad). Transcripts evaluated are listed in Figure 2 . Gene expression profiles represented by the cluster image map in Figure 2 were generated using the National Cancer Institute's CIMminer tool freely accessible online.
Flow cytometry. Corneas were harvested from enucleated eyes of euthanized animals and digested in 2 mg ml À 1 type 1 collagenase from Clostridium histolyticum (Sigma-Aldrich, St Louis, MO) in RPMI 1640 media supplemented with 10% fetal bovine serum, gentamicin, and antibiotic/antimycotic cocktail (Invitrogen, Grand Island, NY) for 2-2.5 h at 37 1C with gentle mechanical trituration every 15 min. The suspension was subsequently filtered through 40-mm mesh, washed with 1% bovine serum albumin in 1 Â PBS (wash buffer), pelleted, and labeled for flow cytometric analysis. Cells were immunolabeled for 30 min at 4 1C following a 15-min incubation with anti-CD16/32 Fc block. Antibodies were obtained from AbD Serotec (Raleigh, NC), eBioscience (San Diego, CA), and BD Biosciences (San Jose, CA) to label CD11b, CD45, F4/80, I-A/I-E, Ly6C, and Ly6G leukocyte antigens. Following labeling, cells were washed twice, fixed in 1% paraformaldehyde (Sigma-Aldrich) and stored overnight at 4 1C. Samples were pelleted and resuspended in 1 ml wash buffer for analysis on a MacsQuant flow cytometer (Miltenyi Biotech, Bergisch Gladbach, Germany).
Immunoassays. Corneas were harvested at the indicated times pi and homogenized in 1 Â PBS containing 1 Â protease inhibitor set 1 (EMD Millipore, Billerica, MA). Supernatants were used at the indicated times pi to evaluate protein concentrations of IFNa by enzyme-linked immunosorbent assay (eBioscience) or CCL2, CCL20, IFNg, IL-1b, and IL-17 by Bio-Plex (Bio-Rad) suspension array according to the manufacturers' directions.
Splenocyte isolation and cultures. Spleens were harvested from euthanized mice, teased into single-cell suspensions, and depleted of erythrocytes as described previously. 28 Immunomagnetic beads (Miltenyi Biotech) were used to isolate CD11b þ splenocytes by positive selection according to the manufacturer's instructions. Cultures of 1 Â 10 5 cells were incubated at 37 1C for 24-48 h at 5% CO 2 in 1 ml RPMI 1640 media supplemented with 10% fetal bovine serum, gentamicin, and antibiotic/antimycotic cocktail (Invitrogen). Supernatants were collected for plaque assay, and cells were labeled for analysis by flow cytometry.
Microscopy. For confocal microscopic analysis of vasculature, mast cells, and tetherin expression, corneolimbal buttons were harvested from enucleated eyes of euthanized animals, fixed in 4% paraformaldehyde for 30 min at 4 1C, washed three times for 15 min in 1% Triton X-100 (Sigma-Aldrich) in 1 Â PBS, and immunolabeled or stained. Samples were washed between primary and secondary antibodies. Antibodies used to label cornea whole mounts were obtained from Abcam (Cambridge, MA), eBioscience, Dako (Carpinteria, CA), EMD Millipore, or Jackson ImmunoResearch (WestGrove, PA). Fluorescein isothiocyanate-conjugated avidin was used to stain peri-corneal mast cells (Biolegend, San Diego, CA) as shown previously. 28 Flat mounts of the tissue were prepared and imaged using an Olympus FV500 confocal microscope (Center Valley, PA). Olympus Fluoview and iMovie (Apple, Cupertino, CA) software were used to generate 3D Z-stack renderings and video highlighting the topographical localization of tetherin expression in the cornea (see Supplementary Movie S1).
In vivo transfection. For corneal knockdown experiments, Ambion Silencer Select siRNA (Invitrogen) was used with Lipofectamine 2000 (Invitrogen) to mediate transfection as previously described. 8 Briefly, partial epithelial debridement of corneas of anesthetized WT mice was conducted to prepare the eye for transfection. Next, 3.33 mmol tetherin-specific or nonspecific scramble control siRNA in supplement-free Dulbecco's modified Eagle's medium media was applied to each cornea in a 10-ml eye drop containing 5 ml Lipofecamine 2000 (Invitrogen). siRNA sequences were designed and validated by the manufacturer. Mice were infected with HSV-1 16 h posttransfection.
